piroxicam usp Price — China Factory EXW 2026

piroxicam usp price Spec: China national standards

China EXW, VAT excluded

Newest China EXW USD 2,365.78 / MT · VAT excluded -767.9469 (-25.00%) as of 20210323

Newest Price 2,365.78

Price Date 20210323

Day's Change -767.95

Day's Range 2,365.78 - 1,597.83

Month's Change +4,042.41

Month's Range 2,365.78 - 6,408.19

Year's Change +166.66

Year's Range 2,365.78 - 2,199.12

The real competition is not among NSAIDs but against urate-lowering therapies. As China's gout management shifts toward long-term uric acid control with febuxostat or allopurinol, ...

Also known as (3R)-2-methyl-4-oxo-N-(pyridin-2-yl)-3,4-dihydro-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 3,4-DIHYDRO-2-METHYL-4-OXO-N-2-PYRIDYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE, 4-Hydroxy-2-Methyl-1,2-Benzothiazine-3-Carboxylic Acid Ethylester-1,1-Dioxide, 4-HYDROXY-2-METHYL-3-(PYRID-2-YL-CARBAMOYL)-2H-1,2-BENZOTHIAZINE 1,1-DIOXIDE

Opinions

How does piroxicam USP compete with newer NSAIDs in China's pharmaceutical market?

The real competition is not among NSAIDs but against urate-lowering therapies. As China's gout management shifts toward long-term uric acid control with febuxostat or allopurinol, acute-relief drugs like piroxicam see less repeat use. API suppliers should monitor chronic disease management policies, not just pain relief trends.

piroxicam usp price context

What drives piroxicam usp prices

How does piroxicam USP compete with newer NSAIDs in China's pharmaceutical market?: The real competition is not among NSAIDs but against urate-lowering therapies. As China's gout management shifts toward long-term uric acid control with febuxos...

How we assess piroxicam usp price

China factory / mainstream market EXW quotes (VAT excluded where shown) - not a single global public index

Regional and specification detail so buyers can compare like-for-like grades

Landed cost figures from our calculator are planning estimates, not a customs ruling

Overview

Piroxicam USP (炎痛喜康, CAS 36322-90-4) is a white to off-white crystalline solid with a melting point of 198–200°C, soluble in water, ethanol, chloroform, and ethyl acetate. It is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class, used to relieve pain and inflammation.

Pharmaceutical: a first-line NSAID for acute gout attacks, typically dosed at 20 mg once daily, with effects comparable to colchicine but fewer gastrointestinal side effects.
Rheumatology: used to manage rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis by controlling inflammation and relieving symptoms.
Analgesia: applied in dental pain and periarthritis of the shoulder, where a single 20 mg dose can provide rapid relief.
Veterinary: administered orally to dogs at 2 mg/kg twice daily for inflammatory conditions.

China's production is predominantly pharmaceutical-grade, with mature synthesis routes based on benzothiazine chemistry. Domestic supply meets local demand, and the product is also exported; no significant import reliance exists. Market trends focus on generic competition and safety monitoring for gastrointestinal and renal effects.

Key domestic producers:
Qilu Pharmaceutical – pharmaceutical grade piroxicam.
Zhejiang Jiuzhou Pharmaceutical – active pharmaceutical ingredient manufacturer.
Shandong Xinhua Pharmaceutical – NSAID product portfolio.

Properties

Name

piroxicam usp

(3R)-2-methyl-4-oxo-N-(pyridin-2-yl)-3,4-dihydro-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

3,4-DIHYDRO-2-METHYL-4-OXO-N-2-PYRIDYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE

4-Hydroxy-2-Methyl-1,2-Benzothiazine-3-Carboxylic Acid Ethylester-1,1-Dioxide

4-HYDROXY-2-METHYL-3-(PYRID-2-YL-CARBAMOYL)-2H-1,2-BENZOTHIAZINE 1,1-DIOXIDE

CAS Number

36322-90-4

EINECS No.

252-974-3

Risk Codes

S26;S36

Safety Description

R22;R25

HS Code

2933990000

Cookie Preferences

Essential Cookies

Analytics Cookies

ChemPriceHub